Unibest

Pharmaceutical intermediates

Maxacalcitol Intermediates

5 pharmaceutical intermediates for Maxacalcitol. Indication: Secondary hyperparathyroidism; Hyperparathyroidism.

提交项目All intermediates

About Maxacalcitol

Originator
Chugai Pharmaceutical Co., Ltd
Indication
Secondary hyperparathyroidism; Hyperparathyroidism
Approved Date
01/21/2011

Available intermediates

5 intermediates currently listed for Maxacalcitol. Request specifications, documentation or a quotation for any item below.

Maxacalcitol intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
PHOSPHINE OXIDE, [2-[3,5-BIS [[(1,1-DIMETHYLETHYL) DIMETHYLSILY]OXY]-2-METHYLENECYCLOHEXYLIDENE]ETHYL]DIPHENYL-,[3S-(1Z,3A,5B0)]81522-68-1//
(1S,3aR,4S,7aS)-1-((S)-1-(3-hydroxy-3-methylbutoxy)ethyl)-7a-methyloctahydro-1H-inden-4-ol192573-37-8//
(1S,3aR,7aR)-1-((S)-1-(3-hydroxy-3-Methylbutoxy)ethyl)-7a-Methylhexahydro-1H-inden-4(2H)-one884488-07-7//
(1S,3aR,7aR)-Octahydro-7a-Methyl-1-((1S)-1-(3-Methyl-3-((triMethylsilyl)oxy)butoxy)ethyl)-4H-Inden-4-one192573-33-4//
(Z)-2-((3S,5R)-3,5-bis((tert-butyldiMethylsilyl)oxy)-2-Methylenecyclohexylidene)ethanol​​81506-24-3​​//

Other programs under M

MaribavirMetoclopramide HClMicafungin SodiumMilvexianMirogabalin besilateMolnupiravirMomelotinib Dihydrochloride MonohydrateMoxifloxacin hydrochloride

Building toward Maxacalcitol?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →